Sangamo Therapeutics, Inc. Soared
Thu, Jan 29, 2026 at 07:27 PM
Sangamo Therapeutics, Inc. (SGMO:NASDAQ) soared at $0.51, a gain of 41%. On Thu, Jan 29, 2026, SGMO:NASDAQ touched a New 2-Week High of $0.51. From Thu, Jan 15, 2026, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Mon, Sep 29, 2025 at $0.77 with a volume of 10M+.
About Sangamo Therapeutics, Inc. (SGMO:NASDAQ)
Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.
Top 10 Gainers:
- TechCreate Group Ltd. Class A (TCGL:NYSEMKT), 889.23%
- Republic Power Group Ltd (RPGL:NASDAQ), 173.86%
- Adlai Nortye Ltd. (ANL:NASDAQ), 88.18%
- Linkers Industries Limited (LNKS:NASDAQ), 71.5%
- ENvue Medical Inc Com Par $0.001 New (FEED:NASDAQ), 66.96%
- Perspective Therapeutics, Inc. (CATX:NYSEMKT), 66.41%
- The GrowHub Limited (TGHL:NASDAQ), 60.89%
- F45 Training Holdings Inc. (FXLV:NYSE), 60%
- Sangamo Therapeutics, Inc. (SGMO:NASDAQ), 40.97%
- Digital Currency X Technology Inc Cl A Ord (DCX:NASDAQ), 34.31%